Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
DTAN
119
HOLDINGS
5%
ALSO IN IDNA
IDNA
44
HOLDINGS
16%
ALSO IN DTAN
SECTOR DRIFT (DTAN minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in DTAN |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
ROCHE HOLDING LTD | 3.8% | 3.8% | 3.8% |
 |
ASTRAZENECA PLC | 3.0% | 4.1% | 3.0% |
 |
SANOFI-AVENTIS | 2.3% | 3.2% | 2.3% |
|
GSK PLC | 2.0% | 3.7% | 2.0% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 1.4% | 3.1% | 1.4% |
DTAN Overweight Relative to IDNA
|
NOVARTIS AG | 3.2% |
|
L'OREAL | 2.8% |
|
SONY CORP | 2.8% |
 |
SIEMENS AG-REG | 2.7% |
|
TOYOTA MOTOR CORP | 2.6% |
|
SHELL PLC | 2.4% |
|
HITACHI LTD | 2.2% |
|
SIEMENS ENERGY AG | 2.2% |
 |
EADS NV | 2.1% |
|
ESSILOR INTERNATIONAL | 1.8% |
DTAN Underweight Relative to IDNA
 |
REVOLUTION MEDICINES, INC. | -6.1% |
|
CELCUITY INC. | -5.7% |
|
REGENERON PHARMACEUTICALS | -5.1% |
|
INCYTE CORP | -4.9% |
|
MERCK & CO. INC. | -4.3% |
 |
GENMAB A/S | -4.0% |
|
ARCELLX, INC. | -3.4% |
|
EXELIXIS INC | -3.3% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
|
JANUX THERAPEUTICS, INC. | -3.1% |